5 completed, 1 active not recruiting, 1 not yet recruiting. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Completed 5, Active not recruiting 1, Not yet recruiting 1 |
Follow Influenza, Human: new trials by email Literature Review of Influenza, Human trials Research Report on Influenza, Human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of RLX-2508-102 in Healthy Volunteers RLX-2508 - Influenza | Early Phase 1 | Not yet recruiting | Atridia Pty Ltd. | 101 | 2026-11-15 | 2026-10-14 |
| Vaccine Pandemic Preparedness Through Airway Immunology Characterization Vaxigripetra, Flumist - Influenza, Human | Early Phase 1 | Active not recruiting | Copenhagen Respiratory Research | 60 | 2025-05-19 | 2026-11-06 |
| Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers Bivalent mRNA SARS-CoV-2 vaccine, Quardrivalent influenza vaccine - COVID - 19 | Early Phase 1 | Completed | Prince of Songkla University | 36 | 2024-03-01 | 2025-12-04 |
| A Study of Acute Respiratory Infections in Global Outpatient Setting Nasal Swab Sample - Acute Respiratory Infection | Early Phase 1 | Completed | Janssen Research & Development, LLC | 245 | 2021-12-20 | 2025-02-03 |
| Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) Treatment Group Live Attenuated Flu Vaccine (LAIV) - Influenza, Human | Early Phase 1 | Completed | University of Alabama at Birmingham | 10 | 2019-11-15 | 2025-06-11 |
| Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine Influenza Vaccine - Immunity, Cellular | Early Phase 1 | Completed | Washington University School of Medicine | 11 | 2018-10-29 | 2025-01-13 |
| Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers wood smoke, clean air - Response of Viral Infection to Woodsmoke | Early Phase 1 | Completed | University of North Carolina, Chapel Hill | 39 | 2014-07-01 | 2015-06-11 |
COVID-19 (2)
Infections (7) · Orthomyxoviridae Infections (7) · RNA Virus Infections (7) · Respiratory Tract Diseases (7) · Respiratory Tract Infections (7) · Virus Diseases (7) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2)
Environment, Controlled (1) · FluMist (1) · Influenza Vaccines (1)
Atridia Pty Ltd. (1) · Copenhagen Respiratory Research (1) · Janssen Research & Development, LLC (1) · Prince of Songkla University (1) · University of Alabama at Birmingham (1) · University of North Carolina, Chapel Hill (1) · Washington University School of Medicine (1)
United States (4) · United Kingdom (2) · Australia (1) · Canada (1) · Denmark (1) · France (1) · Japan (1) · Malaysia (1) · Poland (1) · South Korea (1) · Spain (1) · Taiwan (1) · Thailand (1)
Ali Ellebedy, PhD (1) · Anoma Nellore, MD (1) · Sarunyou Chusri, M.D., Ph.D. (1) · Terry Noah, MD (1)
R01ES013611 (1)